Gene · 148
Papers1,657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,657
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis. | PeerJ | 2021 | 34434654 | PubTator, text mining | PubMed |
| Identification of new target proteins of a Urotensin-II receptor antagonist using transcriptome-based drug repositioning approach. | Sci Rep | 2021 | 34429474 | PubTator, text mining | PubMed |
Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis. | Medicine (Baltimore) | 2021 | 34414962 | PubTator, text mining | PubMed |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Neurosci Biobehav Rev | 2021 | 34411560 | PubTator, text mining | PubMed |
| Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19. | Medicine (Baltimore) | 2021 | 34397905 | PubTator, text mining | PubMed |
| Preventive effects of tamsulosin for postoperative urinary retention after lower limb arthroplasty: A randomized controlled study. | Investig Clin Urol | 2021 | 34387038 | PubTator, text mining | PubMed |
| The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long Journey. | Am J Hypertens | 2021 | 34355740 | PubTator, text mining | PubMed |
| The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors. | Pharmacol Res Perspect | 2021 | 34355529 | PubTator, text mining | PubMed |
| A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. | Mol Syst Biol | 2021 | 34339582 | PubTator, text mining | PubMed |
| Intraoperative Floppy Iris Syndrome Induced by Tamsulosin: The Risk and Preventive Strategies. | Middle East Afr J Ophthalmol | 2021 | 34321822 | PubTator, text mining | PubMed |
| The Potential Effect of Rhizoma coptidis on Polycystic Ovary Syndrome Based on Network Pharmacology and Molecular Docking. | Evid Based Complement Alternat Med | 2021 | 34306142 | PubTator, text mining | PubMed |
| Multiple-Tissue and Multilevel Analysis on Differentially Expressed Genes and Differentially Correlated Gene Pairs for HFpEF. | Front Genet | 2021 | 34306013 | PubTator, text mining | PubMed |
| Deacetylation as a receptor-regulated direct activation switch for pannexin channels. | Nat Commun | 2021 | 34301959 | PubTator, text mining | PubMed |
| Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease. | Cell Commun Signal | 2021 | 34284799 | PubTator, text mining | PubMed |
| Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma. | Front Cell Dev Biol | 2021 | 34249910 | PubTator, text mining | PubMed |
A Randomized Controlled Pilot Study: Combined 595-nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea. | Lasers Surg Med | 2021 | 34233378 | PubTator, text mining | PubMed |
| Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology. | Front Pharmacol | 2021 | 34220510 | PubTator, text mining | PubMed |
| Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function. | Cells | 2021 | 34205363 | PubTator, text mining | PubMed |
| Ligands of Adrenergic Receptors: A Structural Point of View. | Biomolecules | 2021 | 34202543 | PubTator, text mining | PubMed |
| Systematic Investigation of the Effect of Powerful Tianma Eucommia Capsule on Ischemic Stroke Using Network Pharmacology. | Evid Based Complement Alternat Med | 2021 | 34194527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/148/papers?page=17